The Pharmacist's Role in Preventing Antibiotic Resistance

U.S. Pharmacist

Volumn 36, Issue 7, 2011, Pages

  McCoy, Dorothy ^a   Toussaint, Kimberly ^b   Gallagher, Jason C ^c  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTAROLINE; DAPTOMYCIN; LINEZOLID; PENICILLIN G; TELAVANCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BIOCHEMISTRY; CELLULITIS; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; DRUG BIOAVAILABILITY; HEART RATE; HUMAN; KLEBSIELLA PNEUMONIAE; MEDICAL EDUCATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHARMACIST; PSEUDOMONAS AERUGINOSA; SOCIOECONOMICS; VACCINATION;

EID: 79960871868     PISSN: 01484818     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (25)

1. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160-166.
2. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1-12.
3. Li J, Nation RL, Milne RW, et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents. 2005;25(1):11-25.
4. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant. S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666-674.
5. Centers for Disease Control and Prevention (CDC). Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. 2007;56(14):332-336.
6. Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in. Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents. 2006;27(6):468-475.
7. Spellberg B, Powers J, Brass E, et al. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis. 2004;38(9):1279-1286.
8. Kunkel M, Chastre JE, Kollef M, et al. Linezolid vs vancomycin in the treatment of nosocomial pneumonia proven due to methicillin-resistant. Staphylococcus aureus. Presented at the 48th Annual Meeting of the Infectious Diseases Society of America; October 21-24, 2010; Vancouver, BC, Canada.
9. Spellberg B, Talbot GH, Brass EP, et al. Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia. Clin Infect Dis. 2008;47(suppl 3):S249-S265.
10. Spellberg B, Talbot GH, Boucher HW, et al. Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clin Infect Dis. 2009;49(3):383-391.
11. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159-177.
12. Gross R, Morgan AS, Kinky DE, et al. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis. 2001;33(3):289-295.
13. Charani E, Cooke J, Holmes A. Antibiotic stewardship programmes--what's missing. J Antimicrob Chemother. 2010;65(11):2275-2277.
14. California Department of Public Health, State of California. The California antimicrobial stewardship program initiative. www.cdph.ca.gov/programs/hai/Pages/AntimicrobialStewardshipProgramInitiative.aspx. Accessed November 29, 2010.
15. Hall RG, 2nd, Payne KD, Bain AM, et al. Multicenter evaluation of vancomycin dosing: emphasis on obesity. Am J Med. 2008;121(6):515-518.
16. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm. 2009;66(1):82-98.
17. Bauer KA, West JE, Balada-Llasat JM, et al. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant. Staphylococcus aureus/S. aureus blood culture test in patients with. S. aureus bacteremia. Clin Infect Dis. 2010;51(9):1074-1080.
18. Forrest GN, Roghmann MC, Toombs LS, et al. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother. 2008;52(10):3558-3563.
19. Mohr JF, Wagner A, Rex JH. Pharmacokinetic/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patients. Diagn Microbiol Infect Dis. 2004;48(2):125-130.
20. Centers for Disease Control and Prevention. Get smart: know when antibiotics work. www.cdc.gov/getsmart/index.html. Accessed November 18, 2010.
21. Kwong JC, Maaten S, Upshur RE, et al. The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis. 2009;49(5):750-756.
22. American Society of Health System Pharmacists Council on Professional Affairs. ASHP guidelines on the pharmacist's role in immunization. Am J Health Syst Pharm. 2003;60(13):1371-1377.
23. American Pharmacists Association. States where pharmacists can immunize as of June 2009. www.pharmacist.com/AM/Template.cfm?Section=Pharmacist_Immunization_Center1&TEMPLATE=/CM/ContentDisplay.cfm&CONTENTID=21623. Accessed December 13, 2010.
24. Society for Healthcare Epidemiology of America. Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals. www.shea-online.org/about/compendium.cfm. Accessed November 18, 2010.
25. Centers for Disease Control and Prevention. 12 steps to prevent antimicrobial resistance among long-term care residents. www.cdc.gov/drugresistance/healthcare/ltc/12steps_ltc.htm. Accessed October 4, 2010.